Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour

• DOI: 10.1007/bf01277593
• Publication Date: 2005-03-24T06:25:37Z
• Authors: N. Waters; L. L�fberg; S. Haadsma-Svensson; K. Svensson; C. Sonesson; A. Carlsson
• Keywords: Male; 0301 basic medicine; Tetrahydronaphthalenes; Dopamine; Microdialysis; Motor Activity; Binding, Competitive; Rats; Neostriatum; Rats, Sprague-Dawley; Dopamine D2 Receptor Antagonists; 03 medical and health sciences; Animals; Dopamine Antagonists

To establish possible functional differences between the dopamine D2 and D3 receptor we investigated the relation between the ability, for a set of nine mixed dopamine D2 and D3 receptor antagonists, to displace N, N-dipropyl-2-amino-5,6-dihydroxy tetralin (DP-5,6-ADTN) from striatal binding sites and the subsequent behavioural consequences in vivo. Dopamine D2 receptor preferring antagonists are powerful displacers of DP-5,6-ADTN from the striatum. Maximal displacement is followed by strong hypomotility. Displacement of the agonist by the D3 preferring antagonist U99194A is only partial and results in synergistic increases in locomotor activity. Superimposing haloperidol upon GBR12909 leads to a synergistic increase in striatal dialysate dopamine concentrations. This effect is absent when combining GBR12909 with the putative D3 antagonist U99194A. These data give support for the hypothesis that the dopamine D3 receptor is functionally relevant at the postsynaptic level. Here, in contrast to the D2 receptor, it is proposed to exert an inhibitory influence on psychomotor functions.